ARTICLE | Company News
MDRNA, AstraZeneca deal
March 22, 2010 7:00 AM UTC
MDRNA and AstraZeneca's innovation center in China will collaborate on application of MDRNA's DiLA2 di-alkylated amino acid lipid-based RNAi delivery system to treat hepatocellular carcinoma (HCC). Fu...